Antibodies MDPI

Antibodies MDPI Antibodies (ISSN 2073-446, IF 2.7), is an Open Access journal of Antibodies and Antigens published online by
MDPI.

📢 Volume 14, Issue 3 released! Cost-Effective Method for Full-Length Sequencing of Monoclonal Antibodies from Hybridoma ...
10/10/2025

📢 Volume 14, Issue 3 released!
Cost-Effective Method for Full-Length Sequencing of Monoclonal Antibodies from Hybridoma Cells
by Sarah Döring et al.
Link: https://bit.ly/4q9c7eC

📢The last day for Registration of "The 1st International Online Conference by Antibodies"Date: 13-14 October 2025The lin...
09/10/2025

📢The last day for Registration of "The 1st International Online Conference by Antibodies"
Date: 13-14 October 2025
The link: https://bit.ly/4nOpWgh

Welcome to read the editor's choice article:Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the P...
29/09/2025

Welcome to read the editor's choice article:
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
By Lucas Jacobs et al.
The link: https://bit.ly/3KjsSDr

Glad to share the Program Overview of "The 1st International Online Conference by Antibodies"Date: 13-14 October 2025Reg...
26/09/2025

Glad to share the Program Overview of "The 1st International Online Conference by Antibodies"
Date: 13-14 October 2025
Registration Deadline: 9 October
The link: https://bit.ly/4nOpWgh

Welcome to read the editor's choice article:Identification of a Fully Human Antibody VH Domain Targeting Anaplastic Lymp...
25/09/2025

Welcome to read the editor's choice article:
Identification of a Fully Human Antibody VH Domain Targeting Anaplastic Lymphoma Kinase (ALK) with Applications in ALK-Positive Solid Tumor Immunotherapy
by Chuan Chen et al.
The link: https://www.mdpi.com/2073-4468/13/2/39

Welcome to read the editor's choice article:IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization,...
24/09/2025

Welcome to read the editor's choice article:
IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites
by Samuel M. Ailsworth et al.
The link: https://www.mdpi.com/2073-4468/14/2/43

📚Welcome to read the article:Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitat...
23/09/2025

📚Welcome to read the article:
Computational Prediction of Single-Domain Immunoglobulin Aggregation Propensities Facilitates Discovery and Humanization of Recombinant Nanobodies
By Felix Klaus Geyer et al.
The link: https://www.mdpi.com/2073-4468/14/3/73

Welcome to read the article:Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Funct...
22/09/2025

Welcome to read the article:
Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions
By Michelle L. McKeague et al.
The link: https://bit.ly/42EtWYD

📖Welcome to read the editor's choice article:Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Ant...
18/09/2025

📖Welcome to read the editor's choice article:
Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework
by Audrey Kassardjian, Danton Ivanochko, Brian Barber, Arif Jetha, and Jean-Philippe Julien
The link: https://bit.ly/4mrqSpY

Welcome to read the editor's choice article:Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of ...
16/09/2025

Welcome to read the editor's choice article:
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
by Kahlio Mader and Lynn B. Dustin
The link: https://bit.ly/3K2Kt2e

Welcome to read the editor's choice article:Episomal Vectors for Stable Production of Recombinant Proteins and Engineere...
15/09/2025

Welcome to read the editor's choice article:
Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies
by Ian Fallahee and Daniel Hawiger
The link: https://bit.ly/4ppsumJ

Adresse

Basel

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Antibodies MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Kategorie